Q3 2023

Filed Nov 7, 2023 · 10-Q · 38 days after period end · 0000899923-23-000087

Q3 2023 · 10-Q

Revenue

$191.90M

+22.7% vs Q3 2022

Net Income

-$61.30M

N/M vs Q3 2022

EPS Diluted

-$0.75

N/M vs Q3 2022

Operating Income-$60,100,000N/M

Operating Cash Flow

Same quarter

Metric	Q3 2023	Q3 2022	Q3 2021	Q3 2020
Revenue	$191.90M	$156.40M	$167.30M	$145.20M
Net Income	-$61.30M	-$35.10M	$24.60M	-$15.20M
EPS Diluted	-$0.75	-$0.43	$0.30	-$0.20

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR